Sarah Locke
Showing 1–3 of 3 transcripts.
- Milken Institute57 min
Turning Back Time: The Science of Aging
Joanne Kenen, Nir Barzilai, Howard Fillit, Christopher Hite, Joan Mannick, Joanne Cannon, Sami, Aditi Ramdurai, San, Sarah Locke
A panel of experts led by Nir Barzilai, Christopher Healy, Howard Federoff, and Joan Manik is advocating for a paradigm shift in geroscience from treating individual chronic conditions to targeting the underlying biology of aging. The group is pursuing "healthspan compression" through concrete initiatives like the TAME metformin trial, TORC1 inhibitor development, and combination therapies designed to delay multiple diseases simultaneously. While regulatory hurdles and ethical concerns regarding long-term drug use remain, these efforts aim to prove that extending healthy life is economically viable and socially transformative.
- Milken Institute1h 16m
Reducing the Cost and Risk of Dementia
Nora Super, Michael Belleville, Jennie Chin Hansen, Kevin Crain, Jeff Huber, Shari Ling, Sarah Locke, Ian Cramer, Orion, Alan Stevens, Jill Lesser
Leading health officials, financial institutions, and advocacy groups are collaborating to address the rising dementia crisis through CMS payment reforms, specialized geriatric emergency departments, and early detection strategies integrated into banking and home care services. Key initiatives include the ET3 transport model, the expansion of accredited GED facilities, and Bank of America's training of financial advisors to identify cognitive decline, all aimed at shifting from reactive treatment to proactive management. Despite these systemic efforts, significant barriers such as workforce shortages, late-stage diagnoses, and caregiver burnout remain critical challenges that require continued policy innovation and community engagement to resolve.
- Milken Institute1h 16m
Reducing the Cost and Risk of Dementia
Nora Super, Michael Belleville, Jennie Chin Hansen, Kevin Crain, Jeff Huber, Shari Ling, Sarah Locke, Ian Cramer, Orion, Alan Stevens, Jill Lesser
The Milken Institute's new report on reducing dementia costs sparked a multi-sector dialogue involving CMS officials, patient advocates, and industry leaders to address critical gaps in workforce preparedness and community support. Key initiatives highlighted include CMS's expanded billing codes for cognitive screening, the rapid growth of accredited Geriatric Emergency Departments that reduce hospitalizations, and innovative financial strategies to protect caregivers from retirement disparities. Panelists emphasized that effective intervention requires moving beyond isolated medical treatment to holistic models that integrate home care, fraud detection, and policy changes aimed at improving long-term quality of life.